![]() |
We are a European specialty pharmaceutical group dedicated to partnering, discovering and developing innovative, value-added products that improve quality of life and help people to enjoy longer, healthier and more productive lives. Our success will benefit not only the patients whose needs we meet but all our stakeholders whom we serve - our customers, our shareholders, our employees and their families. Latest News
Milan, 6 May 2008
Recordati: positive first quarter 2008 results, sales and income increase Milan, 21 April 2007 Recordati: Orphan Europe filed Carbaglu NDA with the FDA in the U.S. More Latest News Stay Informed?Keep up to date with the latest information by registering for our alert service. |
![]() |
Share PriceAnnual Report![]() [PDF] ![]() (External) | |
![]() | ||||